Venture capitalists report the world is looking up for biotech startups, but caution the outlook holds only for those that can show they can market a product soon. Investors delivered the news at a biotech investment conference in California, still describing the industry as "risky business." Despite the increased hesitation to invest in early-stage research, biotech investment is expected to increase to $5.7 billion this year.

Related Summaries